da Silva GT, da Costa TGP, De Bessa CM, Zamboni MM, Bergmann A, Thuler LCS. Predictors of overall survival in non-small-cell lung cancer patients with metastatic spinal cord compression treated with short-course radiotherapy.
Eur J Cancer Care (Engl) 2021;
30:e13427. [PMID:
33569856 DOI:
10.1111/ecc.13427]
[Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/21/2020] [Revised: 10/09/2020] [Accepted: 12/23/2020] [Indexed: 12/25/2022]
Abstract
Metastatic spinal cord compression (MSCC) is a condition that impacts directly on the patient's prognosis.
OBJECTIVE
The study purpose was to identify predictors of overall survival in non-small-cell lung cancer (NSCLC) patients with MSCC.
METHODS
A cohort study involving NSCLC patients enrolled between 2008 and 2017 was performed. Sixty-four patients treated with short-course radiotherapy were included. Clinical and socio-demographic data were extracted from medical records. Data were analysed using survival analysis and Cox proportional hazard regression analysis.
RESULTS
The median survival time was 2.5 months (95% CI: 1.6-3.5). Patients >60 years had shorter survival than younger patients (HR 1.85; 95% CI 1.06-3.24; p = 0.02), and patients with performance status (PS) >2 had shorter survival than those with PS≤2 (HR 1.93; 95% CI 1.12-3.33; p = 0.01).
CONCLUSION
This study found worse PS and higher age are independent predictors of overall survival in NSCLC patients with MSCC treated with short-course radiotherapy after adjusting the potential confounding factors (PS, age and target therapy).
Collapse